Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Midwest Discussion Group October 2016
Share |
Thursday, October 20, 2016, 9:00AM - 3:30PM 

Sheraton Clayton Plaza Hotel St. Louis
7730 Bonhomme Avenue, St. Louis, MO 63105

Assessment of Criticality of Quality Attributes for Biotherapeutics


The CASSS Midwest Discussion Group is committed to bringing job-relevant education and regulatory trends to CASSS members through meeting programs. The fall discussion group will focus on understanding criticality of quality attributes and their role in demonstrating bioprocess control and overall assurance quality. The discussion will include content from other regional, national or international forum organized by CASSS and speakers from industry and regulatory agencies. The program will also provide a platform for networking with both peers and regulatory authorities.


Learning Objectives: 

1. Discuss current FDA expectations for critical quality attributes selection criteria and assessment approaches
2. Learn industry practices and global implications of established CQAs
3. Understand phase appropriate CQA analysis
    a. Evaluation of manufacturing experience
    b. Statistical analyses
    c. Determination critical vs non-critical



Want more information? Check out the "More in this Section" dropdown box at the top of the page!
Or contact CASSS at 510-428-0740 or





more Calendar

7/10/2018 » 7/12/2018
Cell & Gene Therapy 2018

7/16/2018 » 7/17/2018
CMC Strategy Forum Summer 2018

Featured Members
Linda O. Narhi, Amgen Inc.Visit the CASSS News page to get to know Linda Narhi!

Membership Software Powered by YourMembership  ::  Legal